About Conference

    Dear Colleagues,

     

    Apex Global Meetings is delighted to announce and cordially invite all the participants across the globe to attend the  Global Summit on Toxicology and Applied Pharmacology (GSTAP2025) on March 3-5, 2025, in Dubai, UAE. The theme of the conference is "Advancing Health and Safety: Exploring Innovations and Challenges in Toxicology and Pharmacology." Scientific Tracks designed for this conference will enable the attendees and participants to learn extremes.

     

    GSTAP2025 aims to gather the renowned scientists, young and brilliant researchers, academicians, healthcare professionals, business delegates, and exceptional student communities across the globe under one roof and organize a healthy discussion so that the researchers and authors can present their work at the conference.

    GSTAP2025's objective is to provide a comprehensive global forum for experts and participants from academia to exchange ideas and present the results of on-going research in the most state-of-the-art areas. It will be hosting a forum of plenary, keynote, invited lectures, and oral and poster presentations.

     

    We accept that this gathering will be an exceptionally remunerating, instructive, and collaborative occasion for the attendees.

     

    We look forward to your valuable presence at GSTAP2025 on March 3–5, 2025, in Dubai, UAE. 

     

    Regards,

    Sammi R| Event Manager

    GSTAP2025

    Apex Global Meetings

    Email: secretary@toxicologysummit.org

    Contact: 91-8977610040

     

    Analytical Toxicology

    Animal Testing Methods

    Pharmacovigilence

    Aquatic Toxicology

    Behavior Toxicology

    Behavioral pharmacology

    Biochemical pharmacology

    Cardiotoxicity

    Cardiovascular Pharmacology

    Clinical application of systems

    Computational Toxicology

    Developmental and reproductive toxicology

    Drug discovery, development and evaluation

    Drug Toxicity

    Drugs of abuse

    Ecotoxicology

    Emerging in-vitro models for the toxicity studies

    Experimental and Toxicologic Pathology

    Food Toxicology

    Forensic Toxicology

    Experimental and Toxicologic Pathology

    Psychopharmacology

    Regulatory Affairs

    Pharmacogenetics

    Pharmacological Chemistry

    Intracellular signalling

    Pharmacodynamics

    Pharmacokinetics

    Pharmaco economics.

    The Toxicology Drug Screening Market size is estimated at USD 14.51 billion in 2024, and is expected to reach USD 22.09 billion by 2029, growing at a CAGR of 8.77% during the forecast period (2024-2029).

    The emergence of the COVID-19 pandemic had a significant impact on the market studied. Due to the onset of COVID-19, the need for vaccines and effective treatment development increased. This further increased the extensive use of toxicological screening methods in drug development. According to an article published in the PMC journal in July 2022, various government authorities recommended nonclinical safety studies such as efficacy, biodistribution, and toxicology studies prior to proceeding to First-in-human (FIH) clinical trials for COVID-19 vaccine candidate consisting of a novel product type for which no prior nonclinical and clinical data were available prior. Such instances show that the demand for toxicology testing increased during the pandemic, fueling the market growth, and the studied market is likely to witness growth during the forecast period.

    The studied market is driven by three major factors such as increasing research and development (R&D) expenditure, technological advancements in toxicity screening, and rising demand for toxicological drug screening.

    Chronic diseases are major factors that are fueling the demand for drug discovery and increase in R&D expenditure. Cancer and heart diseases are the major cause of healthcare burden globally. According to the 2022 update by 'Cancer Research UK,' if the recent trends in the incidence of major cancers and population growth are consistent, the new cancer cases will reach 27.5 million worldwide by 2040. With the rise in disease incidence, the major companies are concentrating on developing new drugs and therapeutics, followed by a demand generation for toxicology drug screenings for the same. Hence, the studied market is expected to witness growth over the forecast period.

    The applications of toxicity testing are set to increase with advances in biotechnology and pharmaceuticals, resulting in a demand for the same. Several emerging fields and techniques are providing new insights into understanding biological responses to chemicals in human tissues. Furthermore, there is an increase in pharmaceutical R&D spending globally. According to the IFPMA's 2021 report, the annual R&D spending by the biopharmaceutical industry is 7.3 times higher than that of the aerospace and defense industries, 6.5 times more than the chemicals industry, and 1.5 times more than the software and computer services industry. The source above also mentioned that the biopharmaceutical industry spent USD 196,000 million in 2021, and it is expected to increase to USD 213,000 million by 2024. Thus, the increasing R&D in the biopharmaceutical industry for pharmaceutical product development is garnering the toxicology screening of the drug products, fueling the studied market growth.

    In Vivo toxicology market worldwide is projected to grow by US$2.6 billion, driven by a combined growth of 6.6%. Instruments, one of the segments analysed and sized during this study, show the potential to grow at over 6.3%. The shifting dynamics supporting this growth make it crucial for businesses in this space to stay abreast of the dynamic pulse of the market. Poised to succeed in over US$2.5 billion by the year 2025, instruments can usher in healthy gains, adding important momentum to international growth. Representing the developed world, the U.S. can maintain a 5.6% growth momentum among Europe that continues to stay a crucial part of the world economy, FRG can add over US$90.5 million to the region's size and clout within the next five to six years. Over US$78.7 million of projected demand within the region can come back from the remainder of European markets.

     

     

     

    Important Dates


    Abstract Submission Deadline

    January 25, 2025

    Earlybird Registration Deadline

    November 25, 2024

    Standard Registration Deadline

    January 25, 2024

    Onspot Registration

    March 2, 2025

    Scientific Committee

    Volen Atim

    Dr. Imran Khan

    Department of Biotechnology, Abdul Wali Khan University
    Pakistan
    Volen Atim

    Dr. Uqbah bin Muhammad Iqbal

    National University of Malaysia
    Malaysia
    Volen Atim

    Dr. Bassam Abdul Rasool Hassan

    Department of Pharmacy/ Al Rafidain University College/ Baghdad
    Iraq
    Volen Atim

    Dr. Ahmed G. Hegazi

    Professor of Microbiology and Immunology National Research Center, Dokki, Giza,
    Egypt

    Plenary Speakers

    Dr. Suresh C. Sikka

    Tulane University Health Sciences Center
    USA

    Dr. Xiao-Di Zhang

    The Fourth Military Medical University
    China

    Dr. Danilo A. Tagle

    National Center for Advancing Translational Sciences
    USA

    Dr. Ana Sabater

    National Institutes of Health
    Barcelona

    Prof. Dr. Henrique D. M. Coutinho

    UNIVERSITY OF REGION OF CARIRI - URCA
    Brazil

    Mr. Richard Denk

    SKAN AG
    Switzerland

    Prof. Hasniza Binti Zaman Huri

    Dean at University of Malaya
    Malaysia

    Keynote Speakers

    Dr. Bijendra Singh

    Vice Chancellor, ANDUAT, India

    Dr. Brandon Lucke-Wold

    University of Florida,
    USA

    Invited Speakers

    Dr.Jurgen Gailer

    University of Calgary,
    Canada

    Sr.Lec. Mohammed Irfan

    International Medical University,
    Malaysia

    Media Partners

    Registration

    Registration Includes

    • Access to all conference sessions, poster and exhibition area
    • Conference kit including name tag, program booklet and Abstracts book
    • 2 Coffee breaks and lunch for all the event days of the conference
    • Certificate of participation from Conference chair/ Session chair
    • Access to the all scientific sessions
    • Access to Business Development Sessions and Global Networking Session

    Benefits of Joining Conference

    • Encouraged to publish full length articles in Supporting Journals with discounted APC charges
    • Best Oral, Poster and Young Research Forum (YRF) presentation awards
    • Get Opportunity to Collaborate with future Apex Global Meetings
    • Avail Group Booking Discounts
    • All the articles presented in this conference will be considered for publications as per their quality in SCI / SCIE / SCOPUS / Peer Reviewed journals of Springer and / or other publishers

    Group Booking Discounts

    Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call

    secretary@toxicologysummit.org